This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Vaccibody as. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Innovations in HPV Vaccines by Mona Mari Lindeberg
Introduction
Mona Mari Lindeberg is a prominent inventor based in Oslo, Norway. She has made significant contributions to the field of medical research, particularly in the development of vaccines against human papillomavirus (HPV). Her work focuses on therapeutic compounds that aim to combat HPV-related diseases.
Latest Patents
Mona Mari Lindeberg holds 1 patent related to her innovative work. The patent pertains to vaccines against HPV, specifically targeting HPV16 and HPV18. The invention includes therapeutic DNA vaccines and protein constructs encoding homodimeric peptides. These peptides can be released from a DNA vaccine or utilized separately. Additionally, the patent describes pharmaceutical formulations, host cells, and methods for producing the vaccines, as well as treatment methods for various HPV-induced diseases, including cancers and infectious diseases.
Career Highlights
Lindeberg's career is marked by her dedication to advancing vaccine technology. She works at Vaccibody AS, a company focused on developing innovative therapeutic vaccines. Her research has the potential to significantly impact public health by providing effective solutions for HPV-related conditions.
Collaborations
Mona Mari Lindeberg collaborates with notable colleagues, including Ole Henrik Brekke and Agnete Brunsvik Fredriksen. These partnerships enhance her research efforts and contribute to the development of groundbreaking medical solutions.
Conclusion
Mona Mari Lindeberg's work in the field of HPV vaccines exemplifies her commitment to innovation and public health. Her contributions are paving the way for new therapeutic options in the fight against HPV-related diseases.